IART Q4 2024 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$443M+11.5% YoY

Gross Profit

$249M56.3% margin

Operating Income

$36M8.0% margin

Net Income

$19M4.4% margin

EPS (Diluted)

$0.25

QoQ Revenue Growth

+16.2%

Cash Flow

Operating Cash Flow

$51M

Free Cash Flow

$11M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$4.0B

Total Liabilities

$2.5B

Stockholders' Equity

$1.5B

Cash & Equivalents

$246M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$443M	$397M	+11.5%
Gross Profit	$249M	$226M	+10.0%
Operating Income	$36M	$36M	-1.2%
Net Income	$19M	$20M	-2.0%

Revenue Segments

Codman Specialty Surgical

$315M71%

Tissue Technologies

$128M29%

Geographic Segments

UNITED STATES

$336M80%

Asia Pacific

$44M10%

Europe

$42M10%